Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...
If the idea comes to fruition, cryopreservation could allow cancer patients to ‘freeze’ themselves until medicine advances, or allow humans to ‘outlive’ the apocalypse – as seen in Futurama. AI could ...
TimeShift is described as the world’s first cryopreservation facility and is based on cutting edge AI and new cryopreservation techniques - and it could be used by humans to outlive an apolcalycalypt- ...